Teva Pharmaceutical Industries Limited (TEVA)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Teva Pharmaceutical Industries Limited (TEVA) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $46.09B, a trailing price-to-earnings ratio of 17.3 and a free-cash-flow yield of 2.5%. Over the most recent reported fiscal year, revenue grew 4.3% and free cash flow per share grew 49.0%.

Market cap	$46.09B
Trailing P/E	17.3
FCF yield	2.5%
Revenue growth (YoY)	+4.3%
EPS growth (YoY)	+17.3%
FCF/share growth (YoY)	+49.0%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live TEVA data on Nama Insights →

Recent Congressional trades

Teva Pharmaceutical Industries Limited trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Patty Murray	Senate	Sell	$1,001 - $15,000	—
Angus S King, Jr.	Senate	Sell	$1,001 - $15,000	—